Generation of a Recombinant Cytomegalovirus for Expression of a Hantavirus Glycoprotein

Journal of Virology

Volumn 77, Issue 22, 2003, Pages 12203-12210

  Rizvanov, Albert A ^a,b   Van Geelen, Albert G M ^a,d   Morzunov, Sergey ^a,c   Otteson, Elmer W ^a   Bohlman, Charlotte ^a,b   Pari, Gregory S ^a,b   St Jeor, Stephen C ^a,b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c Nevada State Health Laboratory   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; VIRUS DNA; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HANTAVIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS GENE; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RECOMBINANT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CYTOMEGALOVIRUS; DNA-DIRECTED DNA POLYMERASE; GLYCOPROTEINS; IMMUNIZATION; MOLECULAR SEQUENCE DATA; PEROMYSCUS; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; SIN NOMBRE VIRUS; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0242363234     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.22.12203-12210.2003     Document Type: Article

References (35)

1. Adler, S. P., S. H. Hempfling, S. E. Starr, S. A. Plotkin, and S. Riddell. 1998. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. Pediatr. Infect. Dis. J. 17:200-206.
2. Beisser, P. S., C. Vink, J. G. Van Dam, G. Grauls, S. J. Vanherle, and C. A. Bruggeman. 1998. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72:2352-2363.
3. Berezesky, I. K., P. M. Grimley, S. A. Tyrrell, and A. S. Rabson. 1971. Ultrastructure of a rat cytomegalovirus. Exp. Mol. Pathol. 14:337-349.
4. Borst, E., and M. Messerle. 2000. Development of a cytomegalovirus vector for somatic gene therapy. Bone Marrow Transplant. 25(Suppl. 2):S80-S82.
5. Borucki, M. K., J. D. Boone, J. E. Rowe, M. C. Bohlman, E. A. Kuhn, R. DeBaca, and S. C. St. Jeor. 2000. Role of maternal antibody in natural infection of Peromyscus maniculatus with Sin Nombre virus. J. Virol. 74: 2426-2429.
6. Capps, G. G., and M. C. Zuniga. 1990. A double-labeling method for measuring induction of protein phosphorylation. BioTechniques 8:62-69.
7. Chadwick, E. G., R. Yogev, S. Kwok, J. J. Sninsky, D. E. Kellogg, and S. M. Wolinsky. 1989. Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients. J. Infect. Dis. 160:954-959.
8. Childs, J. E., T. G. Ksiazek, C. F. Spiropoulou, J. W. Krebs, S. Morzunov, G. O. Maupin, K. L. Gage, P. E. Rollin, J. Sarisky, and R. E. Enscore. 1994. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J. Infect. Dis. 169:1271-1280.
9. Chu, Y. K., G. B. Jennings, and C. S. Schmaljohn. 1995. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 69:6417-6423.
10. Dantas, J. R., Jr., Y. Okuno, H. Asada, M. Tamura, M. Takahashi, O. Tanishita, Y. Takahashi, T. Kurata, and K. Yamanishi. 1986. Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151:379-384.
11. Davis-Poynter, N. J., D. M. Lynch, H. Vally, G. R. Shellam, W. D. Rawlinson, B. G. Barrell, and H. E. Farrell. 1997. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71:1521-1529.
12. Engelhardt, J. F., L. Litzky, and J. M. Wilson. 1994. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5:1217-1229.
13. Hartwell, L. H., and T. A. Weiner. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-634.
14. Heiskanen, T., A. Lundkvist, R. Soliymani, E. Koivunen, A. Vaheri, and H. Lankinen. 1999. Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins. Virology 262:321-332.
15. +/CDC28 protein kinases controlling mitotic entry in yeast and frog cells. Mol. Cell. Biol. 9:3860-3868.
16. Lyubsky, S., I. Gavrilovskaya, B. Luft, and E. Mackow. 1996. Histopathology of Peromyscus leucopus naturally infected with pathogenic NY-1 hantaviruses: pathologic markers of HPS viral infection in mice. Lab. Investig. 74:627-633.
17. Maciejewski, J., E. Bruening, R. Donahue, E. Mocarski, N. Young, and S. St. Jeor. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
18. McAllister, R. M., J. E. Filbert, and C. R. Goodheart. 1967. Human cytomegalovirus. Studies on the mechanism of viral cytopathology and inclusion body formation. Proc. Soc. Exp. Biol. Med. 124:932-937.
19. Moro, D., M. L. Lloyd, A. L. Smith, G. R. Shellam, and M. A. Lawson. 1999. Murine viruses in an island population of introduced house mice and endemic short-tailed mice in Western Australia. J. Wildl. Dis. 35:301-310.
20. Netski, D., B. H. Thran, and S. C. St Jeor. 1999. Sin Nombre virus pathogenesis in Peromyscus maniculatus. J. Virol. 73:585-591.
21. Nichol, S. T., C. F. Spiropoulou, S. Morzunov, P. E. Rollin, T. G. Ksiazek, H. Feldmann, A. Sanchez, J. Childs, S. Zaki, and C. J. Peters. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917.
22. Reference removed.
23. Pai, R. K., M. Bharadwaj, H. Levy, G. Overturf, D. Goade, I. A. Wortman, R. Nofchissey, and B. Hjelle. 1999. Absence of infection in a neonate after possible exposure to sin nombre hantavirus in breast milk. Clin. Infect. Dis. 29:1577-1579.
24. 1 events and regulation of cell proliferation. Science 246:603-608.
25. Plotkin, S. A. 1999. Cytomegalovirus vaccine. Am. Heart J. 138:S484-S487.
26. Plotkin, S. A. 1999. Vaccination against cytomegalovirus, the changeling demon. Pediatr. Infect. Dis. J. 18:313-325.
27. Rowe, J. E., S. C. St. Jeor, J. Riolo, E. W. Otteson, M. C. Monroe, W. W. Henderson, T. G. Ksiazek, P. E. Rollin, and S. T. Nichol. 1995. Coexistence of several novel hantaviruses in rodents indigenous to North America. Virology 213:122-130.
28. Schmaljohn, C. S., Y. Chu, A. L. Schmaljohn, and J. M. Dalrymple. 1990. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:3162-3170.
29. Schmaljohn, C. S., S. E. Hasty, and J. M. Dalrymple. 1992. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 10:10-13.
30. Smith, T. A., B. D. White, J. M. Gardner, M. Kaleko, and A. McClelland. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3:496-502.
31. Spaete, R. R., and E. S. Mocarski. 1987. Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 84:7213-7217.
32. Takekoshi, M., F. Maeda-Takekoshi, S. Ihara, S. Sakuma, and Y. Watanabe. 1993. Inducible expression of a foreign gene inserted into the human cytomegalovirus genome. J. Gen. Virol. 74(Pt. 8):1649-1652.
33. 508 deletion in cystic fibrosis. Lancet 8675:1345-1346.
34. Tsukamoto, K., C. Kojima, Y. Komori, N. Tanimura, M. Mase, and S. Yamaguchi. 1999. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257:352-362.
35. Xuan, X., K. Tuchiya, I. Sato, Y. Nishikawa, Y. Onoderaz, Y. Takashima, A. Yamamoto, A. Katsumata, A. Iwata, S. Ueda, T. Mikami, and H. Otsuka. 1998. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector. Vaccine 16:969-976.